In a Danish cohort of 142 patients with palmoplantar keratoderma, researchers identified DSP variants linked to cardiomyopathy risk in seemingly typical cases, highlighting why genetic testing matters beyond just diagnosis.
A recent analysis reveals that nearly 50% of significant dermatologic adverse events linked to anticancer therapies are associated with targeted therapies, with rash, dry skin, and alopecia being the most commonly reported adverse events.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.
New study published in JAMA Dermatology reveals that patients newly diagnosed with alopecia areata face a higher risk of developing psychiatric and autoimmune disorders.
A recent JAMA Dermatology study reveals that over 80% of patients with severe alopecia areata may experience relapse within 152 weeks post-withdrawal, highlighting the need for ongoing maintenance therapy for sustained hair regrowth.
A study in Hormones and Behavior delves into the impact of behavioral problems, environmental noise, maternal stress, and air pollution on hair cortisol levels in 11-year-old children.
With skin pigmentation influencing drug binding and potentially altering therapeutic outcomes, understanding melanin's role in pharmacokinetics is key to advancing equitable treatments.
A large-scale genetic analysis of over 410,000 patients revealed that hypothyroidism increased alopecia areata risk by 40% (OR=1.40), establishing the first causal link between these conditions through Mendelian randomization.